Sol-Gel Technologies clinical trials we track

Check company identity source

Phase 3 3 trials

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 140 participants (planned). After: 113 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2026. After: 20 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Number of New Surgically Eligible BCCs (nSEBs). After: Measure: Number of Participants With New Surgically Eligible Basal Cell Carcinomas (nSEBs).

Check registry source